E-LIB Suche - Ergebnisse für: Gaudy, Allison

1

Efficacy and safety of azacitidine in pediatric patients wi..:

Locatelli, Franco ; Strålin, Karin Belander ; Schmid, Irene...
Pediatric Blood & Cancer. 71 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

2

P883: ALNUCTAMAB (ALNUC; BMS-986349; CC-93269), A BCMA × CD..:

Wong, Sandy W. ; Bar, Noffar ; Victoria Mateos, María...
HemaSphere. 7 (2023) S3 - p. e1220745 , 2023

Link: https://doi.org/10.1097/..

3

Model based assessment of food and acid reducing agent effe..:

Wu, Fan ; Liu, Liangang ; Gaudy, Allison...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2023) 10 - p. 1473-1484 , 2023

Link: https://doi.org/10.1002/..

4

P-034 Alnuctamab (ALNUC; BMS-986349; CC-93269), a BCMA × CD..:

Costa, Luciano ; Bar, Noffar ; Mateos, Maria-Victoria...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S52-S53 , 2023

Link: https://doi.org/10.1016/..

5

Safety, Pharmacokinetics, and Antifibrotic Activity of CC‐9..:

Horan, Gerald ; Ye, Ying ; Adams, Mary...
Clinical Pharmacology in Drug Development. 12 (2023) 8 - p. 779-789 , 2023

Link: https://doi.org/10.1002/..

6

Population Pharmacokinetics of Oral Azacitidine, and Exposu..:

Gaudy, Allison ; Laille, Eric ; Bailey, Rochelle...
Clinical Pharmacology & Therapeutics. 114 (2023) 4 - p. 845-852 , 2023

Link: https://doi.org/10.1002/..

7

A Phase 1, Multicenter, Open-Label Study to Evaluate the Ph..:

Cheng, Yiming ; Ye, Ying ; Gaudy, Allison...
Clinical Pharmacology: Advances and Applications. 15 (2023) - p. 9-19 , 2023

Link: https://doi.org/10.2147/..

8

P825: SOLUBLE FACTORS CORRELATED WITH CYTOKINE RELEASE SYND..:

Boss, Isaac ; Thompson, Ethan ; Gaudy, Allison...
HemaSphere. 7 (2023) S3 - p. e77796ce , 2023

Link: https://doi.org/10.1097/..

9

Exposure‐Response Analysis to Assess the Concentration‐QTc ..:

Cheng, Yiming ; Gaudy, Allison ; Liu, Liangang...
Clinical Pharmacology in Drug Development. 12 (2023) 8 - p. 819-825 , 2023

Link: https://doi.org/10.1002/..

10

Iberdomide in patients with systemic lupus erythematosus: a..:

Furie, Richard A ; Hough, Douglas R ; Gaudy, Allison...
Lupus Science & Medicine. 9 (2022) 1 - p. e000581 , 2022

Link: https://doi.org/10.1136/..

11

Biological impact of iberdomide in patients with active sys..:

Lipsky, Peter E ; Vollenhoven, Ronald van ; Dörner, Thomas...
Annals of the Rheumatic Diseases. 81 (2022) 8 - p. 1136-1142 , 2022

Link: https://doi.org/10.1136/..

12

Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 ..:

Ye, Ying ; Gaudy, Allison ; Thomas, Michael...
Clinical Pharmacology in Drug Development. 11 (2022) 12 - p. 1394-1404 , 2022

Link: https://doi.org/10.1002/..

13

Response to upfront azacitidine in juvenile myelomonocytic ..:

Niemeyer, Charlotte M. ; Flotho, Christian ; Lipka, Daniel B....
Blood Advances. 5 (2021) 14 - p. 2901-2908 , 2021

Link: https://doi.org/10.1182/..

14

First‐in‐Human, Single‐ and Multiple‐Ascending‐Dose Studies..:

Ye, Ying ; Gaudy, Allison ; Schafer, Peter...
Clinical Pharmacology in Drug Development. 10 (2020) 5 - p. 471-485 , 2020

Link: https://doi.org/10.1002/..

15

Evaluation of iberdomide and cytochrome p450 drug-drug inte..:

Gaudy, Allison ; Atsriku, Christian ; Ye, Ying...
European Journal of Clinical Pharmacology. 77 (2020) 2 - p. 223-231 , 2020

Link: https://doi.org/10.1007/..